Plenary 1: THE UNIFYING ROLE OF INNATE IMMUNITY IN THE ETIOLOGY AND PATHOGENESIS OF ALZHEIMER’S DISEASE
Rudolph Tanzi (USA)
Plenary 2: UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER’S PATHOLOGY
Teresa Gomez Isla (USA)
Plenary 3: MONOCLONAL ANTIBODIES TARGETING AMYLOID BETA FOR THE POTENTIAL TREATMENT OF ALZHEIMER’S DISEASE
Roger Nitsch (Switzerland)
Plenary 4: APOE AND TREM2: ZOOMING IN ON CONVERGING MICROGLIAL RESPONSES IN ALZHEIMER’S DISEASE
Guojun Bu (USA)
Plenary 5: NEW INITIATIVES IN DRUG DEVELOPMENT FOR ALS
Angela Genge (Canada)
Plenary 6: NONINVASIVE SENSORY STIMULATION TO TREAT ALZHEIMER’S DISEASE
Li-Huei Tsai (USA)
